NPI: 1588219117 · LAS VEGAS, NV 89178 · Emergency Medicine Physician · NPI assigned 08/09/2019
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (EXECUTIVE VP-CFO) |
| Parent Organization | SPRING VALLEY MEDICAL CENTER |
| NPI Enumeration Date | 08/09/2019 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 52 | $0.00 |
| 2021 | 10,685 | $138K |
| 2022 | 18,748 | $377K |
| 2023 | 15,927 | $411K |
| 2024 | 13,930 | $402K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,885 | 3,358 | $306K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,119 | 2,613 | $293K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,034 | 3,569 | $200K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 590 | 510 | $121K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,504 | 2,028 | $70K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 687 | 666 | $50K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,284 | 1,095 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,759 | 1,419 | $32K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 680 | 572 | $22K |
| 70450 | Computed tomography, head or brain; without contrast material | 241 | 217 | $17K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,808 | 1,484 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 851 | 800 | $15K |
| 71046 | Radiologic examination, chest; 2 views | 892 | 827 | $13K |
| 80053 | Comprehensive metabolic panel | 2,749 | 2,271 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,866 | 3,154 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 735 | 629 | $11K |
| 71045 | Radiologic examination, chest; single view | 1,707 | 1,437 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,026 | 866 | $11K |
| 84484 | 2,213 | 1,246 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,977 | 1,611 | $8K |
| 84702 | 1,295 | 1,103 | $7K | |
| 36415 | Collection of venous blood by venipuncture | 4,175 | 3,350 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 211 | 182 | $6K |
| 83690 | 1,692 | 1,405 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,176 | 997 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,023 | 893 | $3K |
| 81025 | 1,217 | 1,042 | $3K | |
| 81001 | 2,313 | 1,960 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,856 | 1,633 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 97 | 87 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 772 | 680 | $2K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 15 | 14 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 16 | 13 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 684 | 548 | $2K |
| 83605 | 363 | 293 | $1K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 31 | 25 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 275 | 225 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 26 | 26 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,044 | 953 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,092 | 952 | $978.80 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 30 | 29 | $946.11 |
| 85379 | 153 | 136 | $611.79 | |
| 81003 | 700 | 579 | $567.65 | |
| 87077 | 113 | 93 | $503.50 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,464 | 1,203 | $450.55 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 31 | 29 | $447.21 |
| 85610 | 298 | 234 | $311.67 | |
| 85730 | 192 | 150 | $301.46 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 15 | 14 | $290.76 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 15 | 14 | $290.16 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15 | 14 | $290.16 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 56 | 52 | $260.49 |
| 83880 | 16 | 15 | $186.66 | |
| 83735 | 63 | 53 | $175.48 | |
| 73610 | 12 | 12 | $109.02 | |
| 87186 | 34 | 25 | $107.28 | |
| 85027 | 33 | 30 | $102.24 | |
| 82550 | 13 | 12 | $53.67 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 44 | 38 | $29.73 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 17 | 16 | $23.64 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 33 | 30 | $23.24 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 15 | 13 | $0.15 |